Mouse Eosinophils Possess Potent Antibacterial Properties In Vivo
- 1 November 2009
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 77 (11), 4976-4982
- https://doi.org/10.1128/iai.00306-09
Abstract
Eosinophils are best known as the predominant cellular infiltrate associated with asthma and parasitic infections. Recently, numerous studies have documented the presence of Toll-like receptors (TLRs) on the surfaces of eosinophils, suggesting that these leukocytes may participate in the recognition and killing of viruses and bacteria. However, the significance of this role in the innate immune response to bacterial infection is largely unknown. Here we report a novel role for eosinophils as antibacterial defenders in the host response. Isolated mouse eosinophils possessed antipseudomonal properties in vitro. In vivo, interleukin-5 transgenic mice, which have profound eosinophilia, demonstrated improved clearance ofPseudomonas aeruginosaintroduced into the peritoneal cavity. The findings of improved bacterial clearance following adoptive transfer of eosinophils, and impaired bacterial clearance in mice with a congenital eosinophil deficiency, established that this effect was eosinophil specific. The data presented also demonstrate that eosinophils mediate this antibacterial effect in part through the release of cationic secondary granule proteins. Specifically, isolated eosinophil granules had antibacterial properties in vitro, and administration of eosinophil granule extracts significantly improved bacterial clearance in vivo. These data suggest a potent yet underappreciated antibacterial role for eosinophils in vivo, specifically for eosinophil granules. Moreover, the data suggest that the administration of eosinophil-derived products may represent a viable adjuvant therapy for septic or bacteremic patients in the intensive care unit.Keywords
This publication has 53 references indexed in Scilit:
- Allergic airway inflammation and susceptibility to pneumococcal pneumonia in a murine model with real-timein vivoevaluationClinical and Experimental Immunology, 2009
- Allergic pulmonary inflammation in mice is dependent on eosinophil-induced recruitment of effector T cellsThe Journal of Experimental Medicine, 2008
- Eosinopenia is a reliable marker of sepsis on admission to medical intensive care unitsCritical Care, 2008
- Cytokine profiles as markers of disease severity in sepsis: a multiplex analysisCritical Care, 2007
- CD40 Contributes to Lethality in Acute Sepsis: In Vivo Role for CD40 in Innate ImmunityInfection and Immunity, 2003
- Human Eosinophil Peroxidase Induces Surface Alteration, Killing, and Lysis ofMycobacterium tuberculosisInfection and Immunity, 2003
- The Pathophysiology and Treatment of SepsisThe New England Journal of Medicine, 2003
- Septic plasma suppresses superoxide anion synthesis by normal homologous polymorphonuclear leukocytesCritical Care Medicine, 1989
- Eosinopenia of Acute InfectionJCI Insight, 1980
- Behavior of eosinophil leukocytes in acute inflammation. II. Eosinophil dynamics during acute inflammation.JCI Insight, 1975